Eikon Therapeutics, Inc. Common Stock

EIKNNASDAQ • USD
9.50 USD
↗ 0.72 (8.20%)AT CLOSE (11:59 AM EDT)
9.51
↗ 0.01 (0.11%)
POST MARKET (AS OF 05:35 PM EDT)
Post Market
AS OF 05:35 PM EDT
9.51
↗ 0.01 (0.11%)
🟢Market: OPEN
Open?$9.04
High?$9.56
Low?$8.78
Prev. Close?$8.78
Volume?459.2K
Avg. Volume?N/A
VWAP?$9.13
Bid / Ask
Bid?$7.88 × 100
Ask?$11.29 × 100
Spread?$3.41
Midpoint?$9.58
Valuation & Ratios
Market Cap?514.3M
Shares Out?54.1M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
Employees
384
Market Cap
514.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.eikontx.com
Listed
2026-02-05
Address
230 HARRIET TUBMAN WAY
MILLBRAE, CA 94030
Phone: 341-777-0566
MarketsMoversWatchlist